Tumorigenesis in neurofibromatosis: new insights and potential therapies
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 7 (4) , 157-162
- https://doi.org/10.1016/s1471-4914(01)01955-4
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Single Cell Ras-GTP Analysis Reveals Altered Ras Activity in a Subpopulation of Neurofibroma Schwann Cells but Not FibroblastsJournal of Biological Chemistry, 2000
- CD44 Acts Both as a Growth‐ and Invasiveness‐Promoting Molecule and as a Tumor‐Suppressing CofactorAnnals of the New York Academy of Sciences, 2000
- Mouse Models of Tumor Development in Neurofibromatosis Type 1Science, 1999
- Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferationOncogene, 1999
- Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cellsOncogene, 1998
- The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.Genes & Development, 1997
- Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanationJournal of Neurosurgery, 1996
- Expression of the neurofibromatosis 1 (NF1) gene in reactive astrocytes in vitroNeuroReport, 1995
- The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytesNeuron, 1992
- cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene productGenomics, 1991